Evidence
What we know. What we are still measuring.
en-CLEAR has no product-specific clinical results yet. It draws on the Enbiosis record: four clinical study papers on the personalised-diet algorithm and five registered placebo-controlled trials in other health areas.
- 6
- peer-reviewed papers
- 9
- registered clinical studies
- 5
- placebo-controlled randomised trials
Current status
Where en-CLEAR stands
Formulation
Formulated with the Enbiosis Digital Twin & AI Engine.
Format
Food supplement: 90-day programme in three 600 g jars.
Clinical study
Not yet registered
Product-specific clinical study: not yet registered.
Published evidence
A research record you can open and inspect.
Four clinical study papers, from three studies. All four tested the Enbiosis personalised-diet algorithm. None tested en-CLEAR or any other Enbiosis formulation.
Independent recognition
Gold, UK Tech Rocketship Awards 2022, Digital Health category.
ClinicalTrials.gov
Registered trials
Five registered, placebo-controlled randomised trials. Registry status as read on ClinicalTrials.gov on 13 October 2026. None has reported results.
- NCT07453212
Adults with moderate evaporative dry eye linked to meibomian gland dysfunction
130 participants planned, quadruple-masked
Enrolling by invitation
- NCT07619638
Adults with mild to moderate ulcerative colitis
162 participants planned, quadruple-masked
Not yet recruiting
- NCT07736547
Adults with a body mass index of 25 to 40, without diabetes or prediabetes
80 participants planned, quadruple-masked
Enrolling by invitation
- NCT07761546
Men with functional secondary hypogonadism
112 participants planned, triple-masked
Enrolling by invitation
The registry entries do not name a product. A registered trial shows that a study exists and how it is designed. It is not evidence that a formulation works.
Turn evidence into a market-ready partnership.
We work with clinicians, pharmacies, and distributors who value transparent, evidence-led nutrition.
Claim a territory